bluuebunny/crossref_metadata_2025_split huggingface dataset:
Intra-articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee: A 2-Year Follow-up Study
Authors: Jo Chris Hyunchul , Chai Jee Won , Jeong Eui Cheol , Oh Sohee , Shin Ji Sun , Shim Hackjoon , Yoon Kang Sup 
Published: July 2017

Background: The intra-articular injection of mesenchymal stem cells (MSCs) into the knee has shown a potential for the treatment of generalized cartilage loss in osteoarthritis (OA). However, there have been few midterm reports with clinical and structural outcomes. Purpose: To assess the midterm safety and efficacy of an intra-articular injection of autologous adipose tissue–derived (AD) MSCs for knee OA at 2-year follow-up. Study Design: Cohort study; Level of evidence, 3. Methods: Eighteen patients with OA of the knee were enrolled (3 male, 15 female; mean age, 61.8 ± 6.6 years [range, 52-72 years]). Patients in the low-, medium-, and high-dose groups received an intra-articular injection of 1.0 × 107, 5.0 × 107, and 1.0 × 108 AD MSCs into the knee, respectively. Clinical and structural evaluations were performed with widely used methodologies including the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and measurements of the size and depth of the cartilage defect, signal intensity of regenerated cartilage, and cartilage volume using magnetic resonance imaging (MRI). Results: There were no treatment-related adverse events during the 2-year period. An intra-articular injection of autologous AD MSCs improved knee function, as measured with the WOMAC, Knee Society clinical rating system (KSS), and Knee injury and Osteoarthritis Outcome Score (KOOS), and reduced knee pain, as measured with the visual analog scale (VAS), for up to 2 years regardless of the cell dosage. However, statistical significance was found mainly in the high-dose group. Clinical outcomes tended to deteriorate after 1 year in the low- and medium-dose groups, whereas those in the high-dose group plateaued until 2 years. The structural outcomes evaluated with MRI also showed similar trends. Conclusion: This study identified the safety and efficacy of an intra-articular injection of AD MSCs into the OA knee over 2 years, encouraging a larger randomized clinical trial. However, this study also showed potential concerns about the durability of clinical and structural outcomes, suggesting the need for further studies. Clinical Trial Registration: NCT01300598
Do Acute Benefits of Interpersonal Psychotherapy for Posttraumatic Stress Disorder Endure?
Authors: Markowitz John C. , Choo Tse-Hwei , Neria Yuval 
Published: July 2017

Objective: The Psychotherapies for Chronic PTSD randomised trial found that three 14-week psychotherapies acutely benefitted patients with chronic posttraumatic stress disorder (PTSD). Previous research has reported sustained follow-up benefits for prolonged exposure (PE) and relaxation therapy (RT), but few comparable data exist for interpersonal psychotherapy (IPT). We describe 3-month follow-up for acute responders to all 3 treatments. Method: Acute responders, defined a priori as ≥30% improved from baseline, were reevaluated after 3-month no-treatment follow-up by independent evaluators using the Clinician-Administered PTSD Scale (CAPS). Results: Fifty of 110 initial study entrants met acute responder status at week 14. Forty-three (86%) responders entered follow-up: 23 remitters (CAPS ≤20) and 20 responders. At week 26, 27 had achieved remission status, 10 remained responders, and 6 had relapsed. Of week 14 remitters, 8 of 9 PE, all 8 IPT, and 4 of 6 RT patients remained remitted. Relapse rates were 7% (1/9) for PE, 10% (2/20) for IPT, and 33% (3/9) for RT. At week 26, PE showed greater improvement on CAPS than RT ( P = 0.048) and a trend for superiority over IPT ( P = 0.098), with no significant difference between IPT and RT. Depressive symptoms remained low during follow-up. Conclusions: These are the first systematic data on follow-up responder status and persistence of acute treatment benefits in patients receiving individual IPT for chronic PTSD. Patients generally maintained gains across treatments, fluctuating most in RT. Study limitations include small sample size and brief follow-up interval. PTSD research should employ response and remission criteria.
Significant Difference in the Yields ofSukukBonds versus Conventional Bonds
Authors: Ariff M. , Chazi A. , Safari M. , Zarei A. 
Published: July 2017

Bond yields of Treasury and corporate bonds are observed in a listed exchange. This article reports the findings on the market yield behaviour of two types of debt securities in the same exchange, the sharia-compliant sukuk bonds and the normal conventional bonds. There are 17 exchanges where sukuk bonds are traded, and the outstanding value is estimated at US$ 1,200 billion. The average yields of sukuk Treasury bonds are significantly higher (premium) than that of conventional Treasury bonds. On the other hand, investors in the sukuk corporate bonds receive slightly lower returns (discount) of about 25 basis points in the case of long-term sukuk bonds. To the best of our knowledge, this is the first study to verify these differences using appropriate advanced econometric methods. These results have far-reaching implications for the market practices as well as for teaching of bond pricing behaviour since this new form of debt markets is growing at about 17 per cent a year.JEL Classification: F23, F31, G12
Use of a Thoracic Endograft in an Acute Abdominal Aortic Setting: Case Report and Literature Review
Authors: Tasselli Sebastiano , Perini Paolo , Paini Elisa , Milan Luca , Bonvini Stefano 
Published: July 2017

Purpose: We report the case of a thoracic endograft used to achieve exclusion of a ruptured proximal paranastomotic abdominal aortic aneurysm (PAAA) as a consequence of aortic ballooning. Case Report: A type I proximal endoleak was evidenced following endovascular repair of a PAAA with an aortic cuff. The leak was treated with ballooning, which caused distal aortic rupture. A thoracic endograft was deployed inside the cuff, achieving complete exclusion. At 1 year, there are no signs of migration or endoleak with complete PAAA thrombosis, according to computed tomographic angiography. Conclusion: In hostile proximal abdominal aortic neck, challenging anatomies, or urgent cases, the structural adaptability of thoracic endografts could provide safe and successful abdominal aortic endovascular exclusion.
Exploring the Added Value of Video-Stimulated Recall in Researching the Primary Care Doctor–Patient Consultation
Authors: Paskins Zoe , Sanders Tom , Croft Peter R. , Hassell Andrew B. 
Published: July 2017

Background: Video-stimulated recall (VSR) is a method whereby researchers show research participants a video of their own behavior to prompt and enhance their recall and interpretation after the event, for example, in a postconsultation interview. This article describes a process evaluation with the aim of understanding what VSR may have added to findings, to describe participants’ responses to, and the acceptability of, VSR. Method: This evaluation took place in the context of a United Kingdom study concerning the discussion of osteoarthritis in primary care consultations. Postconsultation VSR interviews were conducted with 13 family physicians and 17 patients. Thematic analysis of these interviews and the matched 17 consultations was undertaken. Results: VSR appeared to add value by enabling a deeper understanding of participants’ reactions to specific parts of consultation dialogue, by facilitating participants to express concerns and speak more candidly, and by eliciting a more multilayered narrative from participants. The method was broadly acceptable to participants; however, levels of mild anxiety and/or distress were reported or observed by both doctor and patient participants, and this may explain why some participants reported behavior change as a result of the video. Any reported behavior change was used to inform analysis. Conclusions: This study demonstrates how VSR may enable a more critical, more specific, and more in-depth response from participants to events of interest and, in doing so, generates multiple layers of narrative. This results in a method that goes beyond fact finding and description and generates more meaningful explanations of consultation events.
Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China
Authors: Zhou Lei , Liu Weibin , Li Wei , Li Haifeng , Zhang Xu , Shang Huifang , Zhang Xu , Bu Bitao , Deng Hui , Fang Qi , Li Jimei , Zhang Hua , Song Zhi , Ou Changyi , Yan Chuanzhu , Liu Tao , Zhou Hongyu , Bao Jianhong , Lu Jiahong , Shi Huawei , Zhao Chongbo 
Published: July 2017

Background To determine the efficacy of low-dose, immediate-release tacrolimus in patients with myasthenia gravis (MG) with inadequate response to glucocorticoid therapy in a randomized, double-blind, placebo-controlled study. Methods Eligible patients had inadequate response to glucocorticoids (GCs) after ⩾6 weeks of treatment with prednisone ⩾0.75 mg/kg/day or 60–100 mg/day. Patients were randomized to receive 3 mg tacrolimus or placebo daily (orally) for 24 weeks. Concomitant glucocorticoids and pyridostigmine were allowed. Patients continued GC therapy from weeks 1–4; from week 5, the dose was decreased at the discretion of the investigator. The primary efficacy outcome measure was a reduction, relative to baseline, in quantitative myasthenia gravis (QMG) score assessed using a generalized linear model; supportive analyses used alternative models. Results Of 138 patients screened, 83 [tacrolimus ( n = 45); placebo ( n = 38)] were enrolled and treated. The change in adjusted mean QMG score from baseline to week 24 was −4.9 for tacrolimus and −3.3 for placebo (least squares mean difference: –1.7, 95% confidence interval: −3.5, −0.1; p = 0.067). A post-hoc analysis demonstrated a statistically significant difference for QMG score reduction of ⩾4 points in the tacrolimus group (68.2%) versus the placebo group (44.7%; p = 0.044). Adverse event profiles were similar between treatment groups. Conclusions Tacrolimus 3 mg treatment for patients with MG and inadequate response to GCs did not demonstrate a statistically significant improvement in the primary endpoint versus placebo over 24 weeks; however, a post-hoc analysis demonstrated a statistically significant difference for QMG score reduction of ⩾4 points in the tacrolimus group versus the placebo group. This study was limited by the low number of patients, the absence of testing for acetylcholine receptor antibody and the absence of stratification by disease duration (which led to a disparity between the two groups). ClinicalTrials.gov identifier: NCT01325571
Relationships of Muscle Function and Subjective Knee Function in Patients After ACL Reconstruction
Authors: Bodkin Stephan , Goetschius John , Hertel Jay , Hart Joe 
Published: July 2017

Background: After anterior cruciate ligament reconstruction (ACLR), relationships between objective measures of muscle function and patient-reported outcomes may change over time. Examining these measures at different time frames after surgery may help develop individualized approaches to improve post-ALCR analysis. Purpose: To examine the associations between subjective knee function and lower-extremity muscle function in individual patients at various time points after ACLR. Study Design: Descriptive laboratory study. Methods: Fifty-one participants who underwent primary, unilateral ACLR (15 males, 36 females; mean age, 22.9 ± 4.5 years; mean height, 172.4 ± 10.1 cm; mean weight, 68.7 ± 13.1 kg) were separated into 3 groups depending on time since surgery (early, <2 years; middle, 2-5 years; late, >5 years). Subjective knee function was quantified using the International Knee Documentation Committee (IKDC) subjective knee form and the Knee injury and Osteoarthritis Outcome Score (KOOS). Isometric knee extension and flexion strength were collected at 90 deg/s. Single-leg hop performance was measured using the single hop, triple hop, cross-over hop, and 6-m timed hop. Coefficient correlations were calculated between subjective knee function and objective measures of muscle function for each group. Results: The early group demonstrated moderate correlations between the KOOS and unilateral measures of flexion peak torque ( r = 0.514, P = .035) and flexion power ( r = 0.54, P = .027). The middle group demonstrated the strongest correlations between the KOOS and symmetry measures of the single hop ( r = 0.69, P = .002) and extension work ( r = 0.71, P = .002) as well as unilateral measures of the triple hop ( r = 0.52, P = .034) and extension work ( r = 0.66, P = .004). The late group demonstrated strong correlations between the 6-m timed hop symmetry and the IKDC ( r = 0.716, P = .001) and KOOS ( r = 0.71, P = .001). Conclusion: Patients with a post-ACLR status of less than 2 years exhibited stronger relationships with unilateral strength measures to subjective function; graft type was found to change these relationships. Patients at 2 to 5 years postsurgery demonstrated relationships with both unilateral and symmetry measures of muscle function to subjective function. Patients who were more than 5 years after ACLR exhibited strong associations between hopping symmetry and subjective function. Clinical Relevance: Future clinical guidelines for patients after ACLR may need to consider time since surgery as a potential factor.
Developing and Translating a New Model for Teaching Empowerment Into Routine Chronic Care Management
Authors: Wallace Carolyn A , Pontin David , Dokova Klara , Mikkonen Irma , Savage Eileen , Koskinen Liisa 
Published: July 2017

Background: Health professional education has been criticized for not integrating patient expertise into professional curricula to develop professional skills in patient empowerment. Objective: To develop and translate a new expert patient-centered model for teaching empowerment into professional education about routine chronic care management. Methods: Eight Finnish patients (known as expert patients), 31 students, and 11 lecturers from 4 European countries participated in a new pilot intensive educational module. Thirteen focus groups, artefacts, and an online student evaluation were analyzed using a thematic analysis and triangulated using a meta-matrix. Results: A patient-centered pedagogical model is presented, which describes 3 phases of empowerment: (1) preliminary work, (2) the elements of empowerment, and (3) the expected outcomes. These 3 phases were bound by 2 cross-cutting themes “time” and “enabling resources.” Conclusion: Patient expertise was embedded into the new module curriculum. Using an example of care planning, and Pentland and Feldman’s theory of routine organization, the results are translated into a patient-centered educational model for teaching empowerment to health profession students.
Photocatalytic decolourization of methylene blue using [Zn-Al] layered double hydroxides synthesized at different molar cationic ratios
Authors: Abderrazek Kaouther , Srasra Najoua Frini , Srasra Ezzeddine 
Published: July 2017

Abstract[Zn-Al] layered double hydroxides (LDH) with cationic molar ratios of R = Zn/Al 1–5 were synthesized by the coprecipitation method at constant pH = 10. The samples synthesized and their derived forms obtained after calcination at 500°C and at 900°C (denoted Zn-Al-R, Zn-Al-R-500 and Zn-Al-R-900, respectively), were characterized by X-ray diffraction (XRD), inductively coupled plasmamass spectrometry, scanning electron microscopy, energy-dispersive X-ray spectroscopy, diffuse reflectance spectroscopy and nitrogen physisorption at −196°C. The XRD study showed: (1) the presence of accessory ZnO with the LDH in samples synthesized with R ≥ 3; and (2) the lamellar structure was destroyed at 500°C which made room for a poorly ordered ZnO phase, while calcination at 900°C yielded well crystallized ZnO and ZnAl2O4. The photocatalytic activity of the calcined and the unheated samples was evaluated for the decolourization of methylene blue. The photocatalytic activity was dependent on the cationic ratio R and on the calcination temperature. The sample Zn-Al-3 displayed maximum photocatalytic activity. Calcination at 500 and 900°C improved the photocatalytic activity of LDH synthesized at R = 1 and 2.
Clay minerals interaction with microorganisms: a review
Authors: Cuadros Javier 
Published: July 2017

AbstractInterest in mineral–microbe interaction has grown enormously over recent decades, providing information in a puzzle-like manner which points towards an ever increasingly intimate relationship between the two; a relationship that can be truly termed co-evolution. Clay minerals play a very central role in this co-evolving system. Some 20 years ago, clay scientists looked at clay mineral–microbe studies as a peripheral interest only. Now, can clay scientists think that they understand the formation of clay minerals throughout geological history if they do not include life in their models? The answer is probably no, but we do not yet know the relative weight of biological and inorganic factors involved in driving clay-mineral formation and transformation. Similarly, microbiologists are missing out important information if they do not investigate the influence and modifications that minerals, particularly clay minerals, have on microbial activity and evolution. This review attempts to describe the several points relating clay minerals and microorganisms that have been discovered so far. The information obtained is still very incomplete and many opportunities exist for clay scientists to help to write the real history of the biosphere.
Cation order in the crystal structure of ‘minasgeraisite-(Y)’
Authors: Cooper Mark A. , Hawthorne Frank C. 
Published: July 2017

AbstractThe crystal structure of ‘minasgeraisite-(Y)’, triclinic P1, a = 9.994(4), b = 7.705(3), c = 4.764(2) Å, α = 90.042(9), β = 90.218(14), γ = 90.034(9) (°), V = 366.8(5) Å3 and Z = 1, has been refined to an R1 index of 2.86% for 4170 observed (|Fo| > 4σF) reflections. Significant observed (|Fo| > 40–60 σF) reflections violate the presence of a 21-screw axis and an a-glide plane, negating the space group P21/a previously found for minerals of the gadolinite–datolite group. Averaging of the X-ray data in Laue groups 2/m and $\bar 1$ gives the following agreement indices: 2/m (9.68%) and $\bar 1$ (5.68%). The internal agreement index from averaging of identical reflections collected at multiple positions along the diffraction vector is significantly lower than that for the Laue group $\bar 1$: Rpsi = 2.40%, where 13,109 reflections were collected, 4288 are unique for P1 symmetry, and Rpsi is based on a mean data redundancy factor of > 3. Both the data merging and an |E2–1| value of 0.773 indicate that P1 is the correct space group. The general formula for the gadolinite–datolite group is W2XZ2T2O8V2 (Z = 2) which we have expanded to 20 anions (Z = 1) to show the W-site cation ordering present in ‘minasgeraisite-(Y)’. Bismuth, Ca and REE are ordered over four W sites, with Bi dominant at W1, Ca dominant at W2, and Y dominant at W3 and W4. The dominant constituent at the X sites is a vacancy, and Ca does not occur at the X sites. Significant B and Si are assigned to the Be-dominant Z sites, and the T sites are occupied by Si. The simplified ‘minasgeraisite-(Y)’ formula (Z = 1) is BiCa(Y,Ln)2(□,Mn)2(Be,B,Si)4Si4O16 [(OH),O]4. ‘Minasgeraisite-(Y)’ should be assigned to a triclinic subgroup of the gadolinite–datolite group, and its lower symmetry suggests that Ca-substituted gadolinites and hingganites should be examined for evidence of triclinic symmetry associated with cation order at the W sites.
Categorisation of foot complaints in systemic lupus erythematosus (SLE) from a New Zealand cohort
Authors: Otter Simon J. , Rohan Maheswaran , Davies Kevin A. , Kumar Sunil , Gow Peter , Dalbeth Nicola , Corkill Michael , Panthakalam Sam , Rome Keith 
Published: July 2017

AbstractBackgroundFoot complaints have been shown to be common in systemic lupus erythematosus (SLE) and heterogeneous in nature. We aimed to categorize self‐reported foot complaints in people with SLE and foot symptoms.MethodsA self‐administered validated questionnaire was posted to 406 people with SLE attending adult rheumatology clinics across three health boards in Auckland, New Zealand. In addition to foot pain, vascular complaints, dermatological lesions and neurological symptoms were included in the analysis. Pairwise correlations among the variables were undertaken followed by factor analysis to identify and categorise associations between reported foot complaints.ResultsFrom the questionnaires returned, 93 full datasets were analysed. Participants' were predominantly female (n = 87, 93.7%), with mean (SD) age of 50.4 (14.3) years and a mean (SD) disease duration of 13.1 (11) years. Three categories of foot complaint were determined: ‘foot pain’, ‘skin disorders' and ‘vascular insufficiency’. These three groups provided the best fit (0.91) to describe the wide range of foot complaints reported by those with SLE. Factor analysis for foot pain demonstrated a high positive loading for the inter‐correlation of foot pain in past month (0.83), foot pain today (0.71), intermittent claudication (0.71), numbness (0.62), loss of balance (0.81), swelling (0.59), foot joint pain (0.77), arch pain (0.68) and tendon pain (0.77). Skin disorders demonstrated a very high positive loading for 3 factors skin rash (0.82), blistering skin rash (0.95) and foot ulceration (0.88). In vascular insufficiency a high positive loading for cold feet (0.83), chilblains (0.76) and Raynaud's phenomenon (0.70).ConclusionsThis work suggests people with SLE report three independent categories of foot complaints; foot pain, skin disorders or vascular insufficiency.
Autophagy and inflammation
Authors: Qian Mengjia , Fang Xiaocong , Wang Xiangdong 
Published: July 2017

AbstractAutophagy is a homeostatic mechanism involved in the disposal of damaged organelles, denatured proteins as well as invaded pathogens through a lysosomal degradation pathway. Recently, increasing evidences have demonstrated its role in both innate and adaptive immunity, and thereby influence the pathogenesis of inflammatory diseases. The detection of autophagy machinery facilitated the measurement of autophagy during physiological and pathophysiological processes. Autophagy plays critical roles in inflammation through influencing the development, homeostasis and survival of inflammatory cells, including macrophages, neutrophils and lymphocytes; effecting the transcription, processing and secretion of a number of cytokines, as well as being regulated by cytokines. Recently, autophagy‐dependent mechanisms have been studied in the pathogenesis of several inflammatory diseases, including infectious diseases, Crohn's disease, cystic fibrosis, pulmonary hypertension, chronic obstructive pulmonary diseases and so on. These studies suggested that modulation of autophagy might lead to therapeutic interventions for diseases associated with inflammation. Here we highlight recent advances in investigating the roles of autophagy in inflammation as well as inflammatory diseases.